New Market Research Report: United Kingdom Pharmaceuticals & Healthcare Report Q1 2015

From: Fast Market Research, Inc.
Published: Fri Jan 23 2015


The pharmaceutical and healthcare markets of the United Kingdom are driven by government spending in the form of the National Health System (NHS), which accounts for over 80% of total healthcare spending. With a higher prevalence of non-communicable diseases, coupled with an ageing population, the increased demand for healthcare may lead to the enforcement of cost - containment strategies and move ment away from expensive treatment options.

Headline Expenditure Projections

Pharmaceuticals: GBP24.53bn (USD38.01bn) in 2013 to GBP24.63bn (USD40.89bn) in 2014; +0.44% in local currency terms and +7.6% in US dollar terms.

Full Report Details at
- http://www.fastmr.com/prod/924152_united_kingdom_pharmaceuticals_healthcare_report.aspx?afid=303

Healthcare: GBP148.50bn (USD230.18bn) in 2013 to GBP152.01bn (USD252.34bn) in 2014; +2.4% in local currency terms and +9.6% in US dollar terms.

Risk/Reward Index

In Q115, the UK is ranked as the most attractive market in the Western Europe region (scoring 74.1 out of 100), followed by Germany (72.9) and Switzerland (72.4). The UK's score is boosted by the large multi-billion dollar drug market (market expenditure score of 16.0 out of 20) and large pensionable population (pensionable population score of 7.2 out of 8), but dragged down by a shrinking population (population growth score of 2.0 out of 5).

Key Trends And Developments

* In November 2014, it was announced that the UK has reached a compromise with Germany proposed ending its patent box regime, due to allegations that the scheme gives the UK a competitive advantage over other EU member countries. The transition to a new regime requires tax benefits to be connected directly to research and development (R&D) expenditure and necessitates ratification by the G20 and OECD, according to the Treasury.
* An amendment to the UK's patent law came into effect on October 1, which is expected to attract pharmaceutical research back to the UK. The amendment will eradicate the risk of infringement claims and allow pharmaceutical companies to use a patented product during clinical trials. The...

The United Kingdom Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's United Kingdom Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the British pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's independent pharmaceutical and healthcare industry forecasts for United Kingdom to test other views - a key input for successful budgeting and strategic business planning in the British pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- United States Pharmaceuticals & Healthcare Report Q1 2015
- Germany Pharmaceuticals & Healthcare Report Q1 2015
- Jordan Pharmaceuticals & Healthcare Report Q1 2015
- Malaysia Pharmaceuticals & Healthcare Report Q1 2015
- Peru Pharmaceuticals & Healthcare Report Q1 2015
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »